ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NGM Bio Announces Positive Preliminary Topline Liver Histology of Aldafermin in NASH Patients
March 10, 2020NGM Biopharmaceuticals announced positive preliminary topline results from the 24-week double-blind, randomized, placebo-controlled cohort (Cohort 4) of an adaptive Phase 2 study evaluating the efficacy ... -
Merck gains NASH candidate from NGM Biopharmaceuticals
January 08, 2019Merck has exercised the option to license an investigational product called NGM313 from NGM Biopharmaceuticals under a strategic agreement signed between the companies in 2015.....
Pharma Sources Insight January 2025
